Sabril Patient Registry

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to create a patient registry to collect and analyze information on subjects treated with Sabril and the prescribers of Sabril.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Lundbeck LLC
• Treatments: Vigabatrin

Criteria

Inclusion Criteria:

• All patients in the U.S. who are prescribed Sabril must participate in this patient registry in order to receive Sabril.